NO310176B1 - Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne - Google Patents

Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne Download PDF

Info

Publication number
NO310176B1
NO310176B1 NO20005718A NO20005718A NO310176B1 NO 310176 B1 NO310176 B1 NO 310176B1 NO 20005718 A NO20005718 A NO 20005718A NO 20005718 A NO20005718 A NO 20005718A NO 310176 B1 NO310176 B1 NO 310176B1
Authority
NO
Norway
Prior art keywords
chitosan
cla
composition according
conjugated
composition
Prior art date
Application number
NO20005718A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005718A (no
NO20005718D0 (no
Inventor
Jan Wadstein
Original Assignee
Wadlund As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wadlund As filed Critical Wadlund As
Priority to NO20005718A priority Critical patent/NO310176B1/no
Publication of NO20005718D0 publication Critical patent/NO20005718D0/no
Publication of NO310176B1 publication Critical patent/NO310176B1/no
Publication of NO20005718A publication Critical patent/NO20005718A/no
Priority to PT01993455T priority patent/PT1341517E/pt
Priority to DE60122927T priority patent/DE60122927T2/de
Priority to AU2002216473A priority patent/AU2002216473A1/en
Priority to AT01993455T priority patent/ATE338533T1/de
Priority to ES01993455T priority patent/ES2272566T3/es
Priority to DK01993455T priority patent/DK1341517T3/da
Priority to PCT/NO2001/000437 priority patent/WO2002038123A1/en
Priority to EP01993455A priority patent/EP1341517B1/de
Priority to US10/416,671 priority patent/US7557094B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005718A 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne NO310176B1 (no)

Priority Applications (10)

Application Number Priority Date Filing Date Title
NO20005718A NO310176B1 (no) 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
US10/416,671 US7557094B2 (en) 2000-11-13 2001-11-01 Skin cream composition
EP01993455A EP1341517B1 (de) 2000-11-13 2001-11-01 Hautcremezusammensetzung
PCT/NO2001/000437 WO2002038123A1 (en) 2000-11-13 2001-11-01 A skin cream composition
DE60122927T DE60122927T2 (de) 2000-11-13 2001-11-01 Hautcremezusammensetzung
PT01993455T PT1341517E (pt) 2000-11-13 2001-11-01 Composição em creme para a pele
AU2002216473A AU2002216473A1 (en) 2000-11-13 2001-11-01 A skin cream composition
AT01993455T ATE338533T1 (de) 2000-11-13 2001-11-01 Hautcremezusammensetzung
ES01993455T ES2272566T3 (es) 2000-11-13 2001-11-01 Una composicion de crema cutanea.
DK01993455T DK1341517T3 (da) 2000-11-13 2001-11-01 Et hudcremepræparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20005718A NO310176B1 (no) 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne

Publications (3)

Publication Number Publication Date
NO20005718D0 NO20005718D0 (no) 2000-11-13
NO20005718A NO20005718A (no) 2001-06-05
NO310176B1 true NO310176B1 (no) 2001-06-05

Family

ID=19911788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005718A NO310176B1 (no) 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne

Country Status (10)

Country Link
US (1) US7557094B2 (de)
EP (1) EP1341517B1 (de)
AT (1) ATE338533T1 (de)
AU (1) AU2002216473A1 (de)
DE (1) DE60122927T2 (de)
DK (1) DK1341517T3 (de)
ES (1) ES2272566T3 (de)
NO (1) NO310176B1 (de)
PT (1) PT1341517E (de)
WO (1) WO2002038123A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038123A1 (en) * 2000-11-13 2002-05-16 Wadlund As A skin cream composition

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010347A1 (it) * 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
DE10253042A1 (de) 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) * 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
ES2310948B2 (es) * 2005-02-25 2009-09-16 Universidade De Santiago De Compostela Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US20060240116A1 (en) * 2005-04-22 2006-10-26 David Jolley Bioactive factors in wound healing topical compositions and methods
US20070116778A1 (en) * 2005-11-22 2007-05-24 Fierro Arthur A Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases
ITRM20060108A1 (it) * 2006-03-03 2007-09-04 Colella Gino Composizioni a base di melatonina e sostanze immunostimolanti
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
EP1958639A1 (de) 2007-02-14 2008-08-20 Polichem S.A. Verwendung von Chitosanen zur Behandlung von Entzündungserkrankungen der Nägel
US9132296B2 (en) 2007-05-17 2015-09-15 Ag Essence Antimicrobial solution and methods of making and using the same
US9393261B2 (en) * 2011-07-22 2016-07-19 Body Glide LLC Antimicrobial anti-chafing chelated silver oxide compound
US20080312174A1 (en) * 2007-06-05 2008-12-18 Nitto Denko Corporation Water soluble crosslinked polymers
US8003621B2 (en) * 2007-09-14 2011-08-23 Nitto Denko Corporation Drug carriers
KR101123366B1 (ko) 2008-06-26 2012-03-23 (주)바이오제닉스 우수한 안정성을 갖는 항산화제와 키토산과의 복합체
ES2529586T3 (es) 2008-09-12 2015-02-23 Pharma Gp Aps Composición de calostro
KR101346661B1 (ko) * 2010-11-15 2014-02-06 부경대학교 산학협력단 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물
US11547116B2 (en) * 2012-12-12 2023-01-10 William Wingfield Metal oxide compounds and infusion into polymer compounds
US20140234433A1 (en) * 2013-02-15 2014-08-21 Nicholas V. Perricone Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin
CN114652636B (zh) * 2022-03-10 2023-11-17 广东丸美生物技术股份有限公司 一种抗皱修复组合物及其制备方法和包含该组合物的化妆品

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (de) * 1988-11-28 1990-10-15 Nestle Sa
FR2651131B1 (fr) * 1989-08-23 1994-05-20 Roussel Uclaf Nouvelles compositions cosmetiques contenant du chitosane et de la glucosamine.
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
EP0637450A3 (de) * 1993-08-04 1995-04-05 Collagen Corp Verfahren und Zusammensetzung zur Wiederbelebung von Nerbgewebe.
DE19537297A1 (de) * 1995-07-07 1997-01-09 Paerson & Co Gmbh & Co Kosmetische Präparate mit Wachstumsfaktoren hergestellt aus Milch und Kolostrum von Kühen und Stuten
NO304009B1 (no) * 1997-02-04 1998-10-12 Gunnar Volden Hudpreparat
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
AU2091099A (en) 1997-12-23 1999-07-12 Dcv, Inc. Doing Business As Bio-Technical Resources Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
EP1082096A1 (de) * 1998-03-31 2001-03-14 Natural ASA Zubereitung zur behandlung der haut und ihre verwendung
GB9828379D0 (en) 1998-12-22 1999-02-17 Unilever Plc Skin care composition
GB9828380D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin lightening composition
WO2000059519A2 (de) * 1999-03-31 2000-10-12 Kapitz Carl Heinz Wirkstoff und wirkstoffkombination für mensch und tier
GB9918025D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
NO310176B1 (no) * 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038123A1 (en) * 2000-11-13 2002-05-16 Wadlund As A skin cream composition

Also Published As

Publication number Publication date
DK1341517T3 (da) 2007-01-08
AU2002216473A1 (en) 2002-05-21
WO2002038123A1 (en) 2002-05-16
US20040043963A1 (en) 2004-03-04
ES2272566T3 (es) 2007-05-01
NO20005718A (no) 2001-06-05
DE60122927D1 (de) 2006-10-19
EP1341517A1 (de) 2003-09-10
NO20005718D0 (no) 2000-11-13
EP1341517B1 (de) 2006-09-06
PT1341517E (pt) 2007-01-31
US7557094B2 (en) 2009-07-07
DE60122927T2 (de) 2007-05-24
ATE338533T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
NO310176B1 (no) Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et &lt;beta&gt;-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
Maan et al. The therapeutic properties and applications of Aloe vera: A review
Pandey et al. Aloe Vera: A Systematic Review of its Industrial and Ethno-Medicinal Efficacy.
JPH1053532A (ja) 植物抽出物含有抗アレルギー剤
CN109998986A (zh) 一种二裂酵母冻干粉制剂及其制备方法
CA2897518C (fr) Composition dermatologique topique comportant un peptide antimicrobien cationique couple a un lipide et de l&#39;acide hyaluronique.
US20240216329A1 (en) Putrescine topical formulations
KR20100039532A (ko) 아토피 치료용 하이드로겔 조성물 및 이를 매트릭스로 사용하는 아토피 치료용 매트릭스 패치
EP1713505A1 (de) Methode zur herstellung von pilzglucan-hydrogels mit antibakterieller und immunstimulierender wirkung, sowie dessen verwendung
CN111346053B (zh) 具有生物活性的天然乳化剂及应用
KR20190001166A (ko) 미선나무 추출물을 활용한 피부 재생용 화장료 조성물
JP2007023012A (ja) 沙棘油と酵素類を含むスキンクリーム
CN104224676A (zh) 螺旋藻抗皱防衰老面膜
KR20170103518A (ko) 콜라겐 합성 촉진 및 피부 보습 강화용 조성물
US7306810B1 (en) Skin cream
EP4005608B1 (de) Neue antioxidantische zusammensetzung zur wundheilung
CN104224608A (zh) 螺旋藻抗皱防衰老乳液
JPH104953A (ja) メラトニン酵母を利用した美容・健康向け組成物
US20140357731A1 (en) Healing cream
CN108635618B (zh) 一种具有促进愈合以及修复功能医用胶的制备方法
CN108686260B (zh) 一种复配防疤痕乳剂生物敷料的制备方法
RU2500385C1 (ru) Биологически активная добавка для изготовления косметических средств
US20120276174A1 (en) Therapeutic Treatment of Dermatologic Skin Disorders
JP2003342179A (ja) 老化防止剤
JP6879734B2 (ja) 皮膚浸透促進剤

Legal Events

Date Code Title Description
MK1K Patent expired